256
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Albumin Cys34 adducted by acrolein as a marker of oxidative stress in ischemia-reperfusion injury during hepatectomy

, , , , , , , , , & show all
Pages 831-839 | Received 22 Jan 2016, Accepted 13 Apr 2016, Published online: 12 May 2016

References

  • Brancatisano R, Isla A, Habib N. Is radical hepatic surgery safe? Am J Surg 1998;175:161–163.
  • Jaeschke H. Preservation injury: mechanisms, prevention and consequences. J Hepatol 1996;25:774–780.
  • Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001;21:105–113.
  • Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-reperfusion injury. Am J Surg 2001;181:160–166.
  • Rosser BG, Gores GJ. Liver cell necrosis: cellular mechanisms and clinical implications. Gastroenterology 1995;108:252–275.
  • Bronk SF, Gores GJ. Efflux of protons from acidic vesicles contributes to cytosolic acidification of hepatocytes during ATP depletion. Hepatology 1991;14:626–633.
  • Gasbarrini A, Borle AB, Farghali H, Bender C, Francavilla A, Van Thiel D. Effect of anoxia on intracellular ATP, Na + i, Ca2 + i, Mg2 + i, and cytotoxicity in rat hepatocytes. J Biol Chem 1992;267:6654–6663.
  • Carini R, Autelli R, Bellomo G, Albano E. Alterations of cell volume regulation in the development of hepatocyte necrosis. Exp Cell Res 1999;248:280–293.
  • Jassem W, Fuggle SV, Rela M, Koo DD, Heaton ND. The role of mitochondria in ischemia/reperfusion injury. Transplantation 2002;73:493–499.
  • Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000;32:169–173.
  • Takeuchi D, Yoshidome H, Kato A, Ito H, Kimura F, Shimizu H, et al. Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice. Hepatology 2004;39:699–710.
  • Aldini G, Dalle-Donne I, Colombo R, Facino MR, Milzani A, Carini M. Lipoxidation-derived reactive carbonyl species as potential drug targets in preventing protein carbonylation and related cellular dysfunction. Chem Med Chem 2006;1:1045–1058.
  • Vistoli G, De Maddis D, Cipak A, Zarkovic N, Carini M, Aldini G. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic Res 2013;47:3–27.
  • Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW. Alterations in non-enzymatic biochemistry in uremia: origin and significance of carbonyl stressin long-term uremic complications”. Kidney Int 1999;55:389–399.
  • Alexandrova A, Petrov L, Georgieva A, Kessiova M, Tzvetanova E, Kirkova M, et al. Effect of MG132 on proteasome activity and prooxidant/antioxidant status of rat liver subjected to ischemia/reperfusion injury. Hepatol Res 2008;38:393–401.
  • Barros MA, Vasconcelos PR, Souza CM, Andrade GM, Moraes MO, Costa PE, et al. L-alanyl-glutamine attenuates oxidative stress in liver transplantation patients. Transplant Proc 2015;47:2478–2482.
  • Nastos C, Kalimeris K, Papoutsidakis N, Defterevos G, Pafiti A, Kalogeropoulou H, et al. Antioxidant treatment attenuates intestinal mucosal damage and gut barrier dysfunction after major hepatectomy. Study in a porcine model. J Gastrointest Surg 2011;15:809–817.
  • Grossini E, Pollesello P, Bellofatto K, Sigaudo L, Farruggio S, Origlia V, et al. Protective effects elicited by levosimendan against liver ischemia/reperfusion injury in anesthetized rats. Liver Transpl. 2014;20:361–375.
  • Brenner T, Fleming TH, Spranz D, Schemmer P, Bruckner T, Uhle F, et al. Reactive metabolites and AGE-RAGE-mediated inflammation in patients following liver transplantation. Mediators Inflamm 2013;2013. doi:http://dx.doi.org/10.1155/2013/501430.
  • Aldini G, Carini M, Yeum KJ, Vistoli G. Novel molecular approaches for improving enzymatic and nonenzymatic detoxification of 4-hydroxynonenal: toward the discovery of a novel class of bioactive compounds. Free Radic Biol Med 2014;69:145–156.
  • Aldini G, Vistoli G, Stefek M, Chondrogianni N, Grune T, Sereikaite J, et al. Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products. Free Radic Res 2013;47:93–137.
  • Aldini G, Regazzoni L, Orioli M, Rimoldi I, Facino RM, Carini M. A tandem MS precursor-ion scan approach to identify variable covalent modification of albumin Cys34: a new tool for studying vascular carbonylation. J Mass Spectrom 2008;43:1470–1481.
  • Papac DI, Shahrokh Z. Mass spectrometry innovations in drug discovery and development. Pharm Res 2001;18:131–145.
  • Zhang JY, Wang Y, Dudkowski C, Yang D, Chang M, Yuan J, et al. Characterization of metabolites of Celecoxib in rabbits by liquid chromatography/tandem mass spectrometry. J Mass Spectrom 2000;35:1259–1270.
  • Kostiainen R, Kotiaho T, Kuuranne T, Auriola S. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies. J Mass Spectrom 2003;38:357–372.
  • Liu DQ, Hop CE. Strategies for characterization of drug metabolites using liquid chromatography-tandem mass spectrometry in conjunction with chemical derivatization and on-line H/D exchange approaches. J Pharm Biomed Anal 2005;37:1–18.
  • Orioli M, Aldini G, Benfatto MC, Facino RM, Carini M. HNE Michael adducts to histidine and histidine-containing peptides as biomarkers of lipid-derived carbonyl stress in urines: LC-MS/MS profiling in Zucker obese rats. Anal Chem 2007;79:9174–9184.
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
  • Fiorillo C, Becatti M, Attanasio M, Lucarini L, Nassi N, Evangelisti L, et al. Evidence for oxidative stress in plasma of patients with Marfan syndrome. Int J Cardiol 2010;145:544–546.
  • Zhang W, Wang M, Xie HY, Zhou L, Meng XQ, Shi J, et al. Role of reactive oxygen species in mediating hepatic ischemia-reperfusion injury and its therapeutic applications in liver transplantation. Transplant Proc 2007;39:1332–1337.
  • Granger DN, Kvietys PR. Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol 2015;6:524–551.
  • Tsai YF, Liu FC, Sung WC, Lin CC, Chung PC, Lee WC, et al. Ischemic reperfusion injury-induced oxidative stress and pro-inflammatory mediators in liver transplantation recipients. Transplant Proc 2014;46:1082–1086.
  • Aldini G, Domingues MR, Spickett CM, Domingues P, Altomare A, Sanchez-Gomez FJ, et al. Protein lipoxidation: detection strategies and challenges. Redox Biol 2015;5:253–266.
  • Colzani M, Altomare A, Caliendo M, Aldini G, Righetti PG, Fasoli E. The secrets of Oriental panacea: Panax ginseng. J Proteomics 2016;130:150–159.
  • Aldini G, Vistoli G, Regazzoni L, Gamberoni L, Facino RM, Yamaguchi S, et al. Albumin is the main nucleophilic target of human plasma: a protective role against pro-atherogenic electrophilic reactive carbonyl species? Chem Res Toxicol 2008;21:824–835.
  • Aldini G, Orioli M, Carini M. Protein modification by acrolein: relevance to pathological conditions and inhibition by aldehyde sequestering agents. Mol Nutr Food Res 2011;55:1301–1319.
  • Conklin DJ, Guo Y, Jagatheesan G, Kilfoil PJ, Haberzettl P, Hill BG, et al. Genetic deficiency of glutathione S-transferase p increases myocardial sensitivity to ischemia-reperfusion injury. Circ Res 2015;117:437–449.
  • Chen FT, Yang CM, Yang CH. The protective effects of the proteasome inhibitor bortezomib (velcade) on ischemia-reperfusion injury in the rat retina. PLoS One 2013;8:e64262. doi: 10.1371/journal.pone.0064262.
  • LoPachin RM, Gavin T, Geohagen BC, Zhang L, Casper D, Lekhraj R, et al. β-dicarbonyl enolates: a new class of neuroprotectants. J Neurochem 2011;116:132–143.
  • Kosharskyy B, Vydyanathan A, Zhang L, Shaparin N, Geohagen BC, Bivin W, et al. 2-Acetylcyclopentanone, an enolate-forming 1,3-dicarbonyl compound, is cytoprotective in warm ischemia-reperfusion injury of rat liver. J Pharmacol Exp Ther 2015;353:150–158.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.